09:47 AM EST - InMed Pharmaceuticals Inc. : Reported financial results for the first quarter of fiscal year 2021 which ended September 30, 2020. The Company recorded a net loss of $2.1 million, or $0.41 per share, compared with a net loss of $3.4 million, or $0.65 per share, for the three months ended September 30, 2019. InMed Pharmaceuticals Inc.
shares T.IN are trading up $0.28 at $4.68.
